If impaired beta cell regulation of KATP channel activity or glucokinase activity or HNF activity was the only problem in type 2 diabetes, then its phenotype would resemble that of patients with neonatal diabetes or GCK or HNF mutations, which it does not. The gene discussed is NEFH; the disease is type 2 diabetes mellitus.